[Ropinirole treatment of restless legs].
Kinge
Einar
E
Sandvika Nevrologpraksis og Nasjonalt kunnskapssenter for helsetjenesten, Oslo. einar.kinge.sandneur@as.online.no
Lossius
Morten Ingvar
MI
Mowincel
Petter
P
D000368:Aged; D000978:Antiparkinson Agents / Q000008:administration & dosage* / Q000009:adverse effects; D018491:Dopamine Agonists / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007211:Indoles / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012148:Restless Legs Syndrome / Q000188:drug therapy*; D011795:Surveys and Questionnaires
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole